SCHEMBL10255136

SCHEMBL10255136

CCc1ccc(Oc2cnc3cc(Cl)ccc3n2)cc1C1=C(O)[C@H]2CC[C@H](C2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 2/20 0.39
ALDH1A1 P00352 2/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
ALOX15 P16050 1/20 0.39
NFKB1 P19838 1/20 0.39
HIF1A Q16665 1/20 0.39
GMNN O75496 1/20 0.39
HPGD P15428 1/20 0.39
APEX1 P27695 1/20 0.39
PMP22 Q01453 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
HTT P42858 3/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HRH4 Q9H3N8 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10195450 1.00 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1LMNAMAPT
SCHEMBL10195455 0.88 PDE4B (0.32)
SCHEMBL10254648 0.88 PDE4B (0.32)
SCHEMBL10196012 0.86 CYP1A2 (0.38) CYP1A2CYP3A4ALDH1A1LMNAMAPT
SCHEMBL13190204 0.86 CYP1A2 (0.38) CYP1A2CYP3A4ALDH1A1LMNAMAPT
SCHEMBL10196017 0.86 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1LMNAMAPT
SCHEMBL10196184 0.84 CYP1A2 (0.38) CYP1A2CYP3A4ALDH1A1LMNAMAPT
SCHEMBL10194959 0.82 FFAR4 (0.36) ALDH1A1HIF1ASLC6A3
SCHEMBL10196089 0.81 ALDH1A1 (0.42) CYP1A2CYP3A4ALDH1A1LMNAMAPT
SCHEMBL13190201 0.81 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2387569-B1 HERBCIDES SYNGENTA LTD (GB) 2016-06-15 EP disclosed
US-20140378305-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2014-12-25 US disclosed
US-8865623-B2 Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds SYNGENTA LIMITED (GB) 2014-10-21 US disclosed
US-20120021907-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-01-26 US disclosed
WO-2010081755-A1 NOVEL HERBICIDES SYNGENTA LIMITED (GB) 2010-07-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140378305-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 CYP1A2 11/4885CYP3A4 61/4885ALDH1A1 45/4885
US-20120021907-A1 NOVEL HERBICIDES DDT, CYP4X1, CYP1B1 CYP1A2 67/4885CYP3A4 424/4885ALDH1A1 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.